No Longer the Stuff of Science Fiction: The FDA’s New Policy Approach to Regenerative Medicine Products

December 11, 2017

Shire v. Amneal – Compound Claim Not Obvious and API Supplier Not Liable Under FDA Safe Harbor

October 6, 2015

Patent Licensors Beware – No Challenge Clause Does Not Bar Challenge Before the PTAB

September 28, 2015

Teaching Away Negated by References Disclosing How to Offset Disadvantages

September 15, 2015

For BioPharma, Citing Relevant Art During Prosecution Does Not Appear to Minimize IPR Risk

August 31, 2015

Does the scope of immunity from assertions of patent infringement against U.S. government contractors under 28 U.S.C. § 1498 extend to acts of indirect infringement?

June 15, 2015